A rare complication in a patient taking rivaroxaban: Alveolar hemorrhage

Turk Kardiyol Dern Ars. 2018 Jan;46(1):73-75. doi: 10.5543/tkda.2017.53919.

Abstract

Alveolar hemorrhage (AH) is a heterogeneous clinical syndrome with a high mortality rate that is characterized by extensive bleeding into the alveolar spaces. AH usually develops secondary to immunological disease and, less frequently, to drug use. Presently described is the case of an 86-year-old woman with AH who had been using rivaroxaban for 6 months.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Female
  • Hemorrhage* / chemically induced
  • Hemorrhage* / diagnostic imaging
  • Hemorrhage* / pathology
  • Humans
  • Lung / diagnostic imaging
  • Lung / pathology
  • Pulmonary Alveoli* / diagnostic imaging
  • Pulmonary Alveoli* / drug effects
  • Pulmonary Alveoli* / pathology
  • Pulmonary Alveoli* / physiopathology
  • Rivaroxaban / adverse effects*

Substances

  • Rivaroxaban